出典: meddic


Wikipedia preview

出典(authority):フリー百科事典『ウィキペディア(Wikipedia)』「2012/12/08 10:00:59」(JST)

wiki en

[Wiki en表示]

UpToDate Contents

全文を閲覧するには購読必要です。 To read the full text you will need to subscribe.


  • Comparative Effects of Morning vs Evening Dosing of Extended-Release Hydromorphone on Sleep Physiology in Patients with Low Back Pain: A Pilot Study.
  • Webster LR1, Smith MD, Mackin S, Iverson M.
  • Pain medicine (Malden, Mass.).Pain Med.2014 Oct 3. doi: 10.1111/pme.12577. [Epub ahead of print]
  • OBJECTIVE: To investigate effects of extended-release (ER) hydromorphone dosing time (morning, QAM; evening, QPM) on sleep physiology in patients with chronic low back pain.DESIGN: Randomized, double-blind, placebo-controlled, crossover trial.SETTING: Clinical research site.PATIENTS: Fifteen patient
  • PMID 25279807
  • Influence of intensive care treatment on the protein binding of sufentanil and hydromorphone during pain therapy in postoperative cardiac surgery patients.
  • Saari TI1, Ihmsen H2, Mell J3, Fröhlich K2, Fechner J2, Schüttler J2, Jeleazcov C2.
  • British journal of anaesthesia.Br J Anaesth.2014 Oct;113(4):677-87. doi: 10.1093/bja/aeu160. Epub 2014 Jul 6.
  • BACKGROUND: Our objective was to evaluate the effect of intensive care treatment on the protein binding of sufentanil and hydromorphone in cardiac surgery patients during postoperative analgesia using a target-controlled infusion (TCI) and patient-controlled analgesia (PCA).METHODS: Fifty adult pati
  • PMID 25001621
  • Sulfation of opioid drugs by human cytosolic sulfotransferases: metabolic labeling study and enzymatic analysis.
  • Kurogi K1, Chepak A1, Hanrahan MT1, Liu MY2, Sakakibara Y3, Suiko M3, Liu MC4.
  • European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences.Eur J Pharm Sci.2014 Oct 1;62:40-8. doi: 10.1016/j.ejps.2014.05.003. Epub 2014 May 14.
  • The current study was designed to examine the sulfation of eight opioid drugs, morphine, hydromorphone, oxymorphone, butorphanol, nalbuphine, levorphanol, nalorphine, and naltrexone, in HepG2 human hepatoma cells and human organ samples (lung, liver, kidney, and small intestine) and to identify the
  • PMID 24832963


Dilaudid (hydromorphone) is a narcotic pain reliever used to treat moderate to severe pain. Includes Dilaudid side effects, interactions and indications. ... Dilaudid side effects Get emergency medical help if you have any of these signs ...
Learn about the prescription medication Dilaudid (Hydromorphone Hydrochloride), drug uses, dosage, side effects, drug interactions, warnings, reviews and patient labeling. ... Each 5 mL (1 teaspoon) of DILAUDID ORAL LIQUID ...


Dilaudid prescription drug /side effects Original file ‎ (2,048 × 1,536 pixels Dilaudid addiction is a growing concernDilaudid prescription drug /side effects Dilaudid prescription drug /side effects Dilaudid Addiction



  [★] ヒドロモルフォン